Immune-related diagnostic markers for benign prostatic hyperplasia and their potential as drug targets

This study introduces novel immune-related diagnostic markers for BPH and highlights their promise as new drug targets, providing a valuable approach for predictive diagnosis and targeted therapy of BPH.